ArticleCancer gene therapy2022

Lnc-ABCA12-8 confers acquired resistance to gefitinib in non-small cell lung cancer by regulating the alternative splicing of fibronectin 1 in the IIICS region.

Shuai He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.